ChemicalBook >> CAS DataBase List >>2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate

2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate

CAS No.
170098-38-1
Chemical Name:
2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate
Synonyms
Entereg;Alvimopan 2H2O;Alvimopan hydrate;Ly 246736 dihydrate;Alvimopan dihydrate;Ly 246736 2-hydrate;ADL 8-2698 dihydrate;156053-89-3 (Anhydrous);Alvimopan dihydrate, >=99%;Alvimopan Dihydrate Labeled d7
CBNumber:
CB21261077
Molecular Formula:
C25H36N2O6
Molecular Weight:
460.57
MDL Number:
MFCD00927248
MOL File:
170098-38-1.mol
MSDS File:
SDS
Last updated:2023-05-18 11:31:20

2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate Properties

Melting point 210-213°
alpha D25 +51.8° (c = 1.0 in DMSO)
storage temp. 2-8°C
solubility Soluble in DMSO
form Powder
FDA UNII 677C126AET
NCI Drug Dictionary Entereg

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H332-H335
Precautionary statements  P261-P280-P305+P351+P338

2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-1540 Alvimopan(dihydrate) 98.70% 170098-38-1 5mg $110 2021-12-16 Buy
ApexBio Technology A3163 Alvimopandihydrate 170098-38-1 5mg $159 2021-12-16 Buy
ChemScene CS-1540 Alvimopan(dihydrate) 98.70% 170098-38-1 10mg $160 2021-12-16 Buy
ApexBio Technology A3163 Alvimopandihydrate 170098-38-1 10mg $252 2021-12-16 Buy
ChemScene CS-1540 Alvimopan(dihydrate) 98.70% 170098-38-1 50mg $480 2021-12-16 Buy
Product number Packaging Price Buy
CS-1540 5mg $110 Buy
A3163 5mg $159 Buy
CS-1540 10mg $160 Buy
A3163 10mg $252 Buy
CS-1540 50mg $480 Buy

2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate Chemical Properties,Uses,Production

Description

Alvimopan is a μ-opioid receptor antagonist approved in the U.S. in May 2008 for the treatment of post-operative ileus (POI) – a temporary dysfunction of the gastrointestines. Alvimopan does not penetrate the central nervous system (CNS) and acts as a peripheral antagonist. The molecule inhibits the negative effects of opioids on the gastrointestinal (GI) system without inhibiting the desired analgesic effects of CNS penetrant opioids.

Uses

Treatment of opioid-induced bowel dysfunction, opioidinduced nausea and vomiting, postoperative ileus, idiopathic constipation, and irritable bowel syndrome (peripherally restricted mu opioid receptor antagonist).

Synthesis

Several synthetic routes have been disclosed, and the process route is described in the scheme. This route was performed on kilogram scale and no yields were reported beyond the generation of compound 8. 3-Bromophenol 1 was treated with isopropyl bromide and potassium carbonate at 60-65 ??C for 16 h to give 3-isopropyoxy bromobenzene 2. Bromide 2 was added to a suspension of Mg turnings in THF at 40-60 ??C generating the corresponding Grignard reagent to which a solution of 1,3-dimethylpiperidone 3 in THF was added as four separate fractions over a period of 2 h. Upon completion, the reaction mixture was quenched with aqueous ammonium chloride, the product was extracted into heptane and crystallized out of solution and was isolated by filtration to provide a cis-(?à) enriched mixture of piperidone alcohol 4 in 97% purity. This mixture was recrystallized from heptane to afford exclusively the cis-(?à) piperidone 4 in 97% purity and 66% yield. Piperidone alcohol 4 was treated with ethylchloroformate and triethyl amine at 0??C and warmed to room temperature over 3 h. The resulting ethylcarbonate was resolved via classical resolution with (+)-di-p-toluyl-Dtartaric acid and then recrystallized from ethanol to give 5 in 99% purity and 99.5% ee. The conversion of 5 to 3,4-trans dimethyl piperidine 8 followed the sequence described by Werner, et. al. as no experimental was disclosed in the process patent for this sequence. The (+)-DTTA salt 5 was treated with sodium hydroxide to liberate the free base which then underwent thermal elimination of the carbonate at 190 ??C in decalin to give the desired trisubstituted olefin 6 in 92% yield. Treatment of piperidine 6 with n-BuLi followed by addition of dimethyl sulfate at -50 ??C gave the desired 3,4-trans-dimethyl enamine 7. Due to the reactivity of the dimethyl sulfate, only one equivalent was used and the reaction had to be quenched into aqueous ammonium hydroxide to avoid N-methylation. The crude enamine 7 was reduced with sodium borohydride and purified by crystallization with (+)-DTTA, giving (+)-DTTA salt 8 in 65% overall yield from 5. Additionally, the crystallization provided 8 with less than 1% impurities and 98.8% ee. The free base of 8 was liberated upon treatment with sodium hydroxide and reacted with phenyl chloroformate at 80-85 ??C, to effectively demethylate the nitrogen. The resulting crude phenylcarbamate 9 was refluxed in HBr/acetic acid for 18 h to simultaneously cleave the isopropyl ether and carbamate protecting groups to give the aminophenol 10, which was precipitated out of solution and collected by filtration. Amine 10 was then treated with methylacrylate (11) in THF at 40-45 ??C for 18-19 h to give the intermediate 12, which was transferred directly into a solution of LDA. A solution of benzyl bromide in THF was added to the enolate of 12 at -20 ??C and upon complete benzylation, 13 was isolated as its HCl salt. Ester 13 was hydrolyzed with sodium hydroxide to give 14, which was coupled to glycine ethyl ester hydrochloride 15 in the presence of DCC, HOBT and triethylamine in THF providing crude ethyl ester 16. Finally, ester 16 was hydrolyzed with sodium hydroxide to give alvimopan (I), which was purified by crystallization from the reaction mixture in 99.2% purity and 99% ee.

Synthesis_170098-38-1

2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 97)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Daken Advanced Materials Co.,Ltd
+86-371-66670886 info@dakenam.com China 15928 58
Hangzhou Cyanochem Co., Ltd.
+86 17788583750 sales@cyanochem.com CHINA 283 58
Xiamen AmoyChem Co., Ltd
+86-592-6051114 +8618959220845 sales@amoychem.com China 6387 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 47465 58
career henan chemical co
+86-0371-86658258 15093356674; factory@coreychem.com China 29826 58
Hubei Ipure Biology Co., Ltd
+8613367258412 ada@ipurechemical.com China 10326 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
Shanxi Xuanran Import and Export Trade Co., Ltd.
+8617735180244 mike_yan@xuanranglobal.com CHINA 4022 58
AFINE CHEMICALS LIMITED
0571-85134551 info@afinechem.com CHINA 15377 58
Finetech Industry Limited
+86-27-87465837 +8618971612321 info@finetechnology-ind.com China 9702 58

View Lastest Price from 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate pictures 2020-02-14 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate
170098-38-1
US $7.00 / KG 1KG 99% 100KG Career Henan Chemical Co

170098-38-1(2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate)Related Search:

2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi dyl]propanoyl]amino]acetic acid dihydrate [[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl]-3-phenylpropanoyl]amino]acetic acid dehydrate (((2S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoyl)amino)acetic acid dihydrate 156053-89-3 (Anhydrous) Alvimopan hydrate Entereg Glycine, N-((2S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, dihydrate Glycine, N-(2-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-,dihydrate, (3R-(1(S*),3-alpha,4-alpha))- Ly 246736 dihydrate AlviMopan(ADL-8-2698,LY-246736) ADL 8-2698 dihydrate Glycine,N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-diMethyl-1-piperidinyl]Methyl]-1-oxo-3-phenylpropyl]-,hydrate (1:2) Alvimopan dihydrate, >=99% Alvimopan 2H2O Alvimopan dihydrate N-[(2S)-2-[[(3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]glycine dihydrate N-{(2S)-2-Benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]propanoyl}glycine 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid,dihydrate LY 246736 DIHYDRATE; ADL 8-2698 DIHYDRATE Alvimopan dihydrate (LY246736 dihydrate) Ly 246736 2-hydrate 2-((S)-2-Benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic acid dihydrate Alvimopandihydrate/ADL8-2698dihydrate Alvimopan Dihydrate Labeled d7 170098-38-1 C25H32N2O42H2O C25H36N2O6 API